State of the Art (SotA)

What does State of the Art mean?

The European Medical Device Regulation 2017/745 (MDR) and In-Vitro Diagnostic Regulation 2017/746 (IVDR) often state the need to “take into account the generally acknowledged state of the art”. However, the concept of the “state of the art” (SotA) is not legally defined and thus differs between various guidance documents. The International Medical Device Regulators Forum (IMDRF) has provided the following definition of the SotA for medical devices: Developed stage of current technical capability and/or accepted clinical practice in regard to products, processes and patient management, based on the relevant consolidated findings of science, technology and experience. Note: The state-of-the-art embodies what is currently and generally accepted as good practice in technology and medicine. The state-of-the-art does not necessarily imply the most technologically advanced solution. The state-of-the-art described here is sometimes referred to as the ‘generally acknowledged state-of-the-art (IMDRF/GRRP WG/N47 FINAL:2018 Essential Principles of Safety and Performance of Medical Devices and IVD Medical Devices).

AML Christensen’s service
One of the objectives of the clinical evaluation for your medical device (or performance evaluation for your in-vitro diagnostic medical device) is to demonstrate that your device is/remains state-of-the art in its intended medical field. To be able to draw such conclusions, we will first need to describe the following:
  • What is the medical field for your device?
  • What are the clinical manifestations related to the conditions treated/diagnosed by your device?
  • What is the prevalence of the condition?
  • How has the medical field evolved? (historical context of the treatment options)
  • What alternative treatment options are available on the market?
  • What is recommended by clinical practice guidelines? What is the standard of care?
  • How well does other similar benchmark devices perform?
  • Which hazards and emerging risks are related to the treatment? 
  • What are the benefits and risks with your type of device when compared to the alternative options?
  • Are there any potential unmet needs?
At AML Christensen we have the know-how to demonstrate the state of the art for your device as based on a systematic and non-biased literature search methodology.

The European Medical Device Regulation 2017/745 (MDR) and In-Vitro Diagnostic Regulation 2017/746 (IVDR) often state the need to “take into account the generally acknowledged state of the art”. However, the concept of the “state of the art” (SotA) is not legally defined and thus differs between various guidance documents. The International Medical Device Regulators Forum (IMDRF) has provided the following definition of the SotA for medical devices: Developed stage of current technical capability and/or accepted clinical practice in regard to products, processes and patient management, based on the relevant consolidated findings of science, technology and experience. Note: The state-of-the-art embodies what is currently and generally accepted as good practice in technology and medicine. The state-of-the-art does not necessarily imply the most technologically advanced solution. The state-of-the-art described here is sometimes referred to as the ‘generally acknowledged state-of-the-art (IMDRF/GRRP WG/N47 FINAL:2018 Essential Principles of Safety and Performance of Medical Devices and IVD Medical Devices).